Nycomed Pharma As
Records under this name other than patents Nycomed Pharma As holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,258,576 | Particulate comprising a calcium-containing compound and a sugar alcohol Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,101,565 | Dissolution stability of calcium carbonate tablets Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,846,101 | Film-Coated And/Or Granulated Calcium-Containing Compounds and Use Thereof in Pharmaceutical Compositions Formerly held Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 9,999,634 | Dissolution stability of calcium carbonate tablets Formerly held Lapsed on the fee record Ended Jun 19, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2026 | From the USPTO record |
| US 10,357,460 | Particulate comprising a calcium-containing compound and a sugar alcohol Formerly held Term ended Term ended Apr 26, 2026 · From the USPTO record | Term ended | Term ended Apr 26, 2026 | From the USPTO record |
| US 8,642,081 | Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance Formerly held Lapsed on the fee record Ended Feb 4, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2026 | From the USPTO record |
| US 7,098,315 | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge Formerly held Term ended Term ended Oct 13, 2022 · From the USPTO record | Term ended | Term ended Oct 13, 2022 | From the USPTO record |
| US D564,086 | Tablet Formerly held Term ended Term ended Mar 11, 2022 · From the USPTO record | Term ended | Term ended Mar 11, 2022 | From the USPTO record |
| US 6,733,774 | Carrier with solid fibrinogen and solid thrombin Formerly held Term ended Term ended Mar 6, 2022 · From the USPTO record | Term ended | Term ended Mar 6, 2022 | From the USPTO record |
| US 7,052,713 | Carrier with solid fibrinogen and solid thrombin Formerly held Term ended Ended no later than Jan 25, 2022 · From the USPTO record | Term ended | Ended no later than Jan 25, 2022 | From the USPTO record |